Security National Bank of Sioux City Iowa IA Reduces Position in iShares Biotechnology ETF (NASDAQ:IBB)

Security National Bank of Sioux City Iowa IA reduced its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,265 shares of the financial services provider’s stock after selling 97 shares during the period. Security National Bank of Sioux City Iowa IA’s holdings in iShares Biotechnology ETF were worth $1,272,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. Future Financial Wealth Managment LLC acquired a new position in iShares Biotechnology ETF in the first quarter valued at approximately $27,000. Bbjs Financial Advisors LLC acquired a new position in shares of iShares Biotechnology ETF in the 2nd quarter valued at $31,000. Pacifica Partners Inc. grew its position in shares of iShares Biotechnology ETF by 118.2% in the 1st quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock valued at $33,000 after buying an additional 130 shares during the last quarter. YHB Investment Advisors Inc. acquired a new stake in iShares Biotechnology ETF during the 1st quarter worth $37,000. Finally, Mather Group LLC. purchased a new stake in iShares Biotechnology ETF in the first quarter valued at $57,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Up 0.5 %

Shares of IBB stock opened at $144.90 on Friday. iShares Biotechnology ETF has a 1 year low of $111.83 and a 1 year high of $150.57. The stock’s 50-day moving average is $145.70 and its two-hundred day moving average is $138.83.

iShares Biotechnology ETF Dividend Announcement

The company also recently declared a dividend, which will be paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th will be given a dividend of $0.2005 per share. The ex-dividend date of this dividend is Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.